On Tuesday, Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) opened higher 2.41% from the last session, before settling in for the closing price of $16.57. Price fluctuations for ARWR have ranged from $9.57 to $30.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -53.80%. Company’s average yearly earnings per share was noted 103.90% at the time writing. With a float of $115.20 million, this company’s outstanding shares have now reached $138.06 million.
The extent of productivity of a business whose workforce counts for 609 workers is very important to gauge. In terms of profitability, gross margin is 98.16%, operating margin of -21.74%, and the pretax margin is -27.93%.
Arrowhead Pharmaceuticals Inc (ARWR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arrowhead Pharmaceuticals Inc is 16.58%, while institutional ownership is 74.55%. The most recent insider transaction that took place on Apr 11 ’25, was worth 583,692. In this transaction Chief Executive Officer of this company sold 50,800 shares at a rate of $11.49, taking the stock ownership to the 3,921,255 shares. Before that another transaction happened on Apr 10 ’25, when Company’s Chief Executive Officer sold 50,000 for $10.87, making the entire transaction worth $543,500. This insider now owns 3,972,055 shares in total.
Arrowhead Pharmaceuticals Inc (ARWR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 103.90% per share during the next fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Check out the current performance indicators for Arrowhead Pharmaceuticals Inc (ARWR). In the past quarter, the stock posted a quick ratio of 5.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.30. Likewise, its price to free cash flow for the trailing twelve months is 509.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.95 in the next quarter and is forecasted to reach -3.40 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
The latest stats from [Arrowhead Pharmaceuticals Inc, ARWR] show that its last 5-days average volume of 1.36 million was inferior to 1.91 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 76.05%. Additionally, its Average True Range was 0.86.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 60.31%, which indicates a significant decrease from 86.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.46% in the past 14 days, which was lower than the 71.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.93, while its 200-day Moving Average is $18.41.
